FOLH1 and prostate cancer: The ptxl was incorporated into the PLA-PEG copolymer which was then attached to A10 PSMA aptamer with 5'-NH2 modifications and was tested for successful uptake in human prostate cancer cells (LNCAP and PC3) (Tong et al., 2010).